Risk factors of postoperative pulmonary complications in patients with asthma and COPD

Takanori Numata, Katsutoshi NakayamaSatoko FujiiYoko YuminoNayuta SaitoMasahiro YoshidaYusuke KuritaKenji KobayashiSaburo ItoHirofumi UtsumiHaruhiko YanagisawaMitsuo HashimotoHiroshi WakuiShunsuke MinagawaTakeo IshikawaHiromichi HaraJun ArayaYumi Kaneko and Kazuyoshi Kuwano

Abstract

Background

Postoperative pulmonary complications (PPC) in patients with pulmonary diseases remain to be resolved clinical issue. However, most evidence regarding PPC has been established more than 10 years ago. Therefore, it is necessary to evaluate perioperative management using new inhalant drugs in patients with obstructive pulmonary diseases.

Methods

April 2014 through March 2015, 346 adult patients with pulmonary diseases (257 asthma, 89 chronic obstructive pulmonary disease (COPD)) underwent non-pulmonary surgery except cataract surgery in our university hospital. To analyze the risk factors for PPC, we retrospectively evaluated physiological backgrounds, surgical factors and perioperative specific treatment for asthma and COPD.

Results

Finally, 29 patients with pulmonary diseases (22 asthma, 7 COPD) had PPC. In patients with asthma, smoking index (≥ 20 pack-years), peripheral blood eosinophil count (≥ 200/mm3) and severity (Global INitiative for Asthma(GINA) STEP ≥ 3) were significantly associated with PPC in the multivariate logistic regression analysis [odds ratio (95% confidence interval) = 5.4(1.4–20.8), 0.31 (0.11–0.84) and 3.2 (1.04–9.9), respectively]. In patients with COPD, age, introducing treatment for COPD, upper abdominal surgery and operation time (≥ 5 h) were significantly associated with PPC [1.18 (1.00–1.40), 0.09 (0.01–0.81), 21.2 (1.3–349) and 9.5 (1.2–77.4), respectively].

Conclusions

History of smoking or severe asthma is a risk factor of PPC in patients with asthma, and age, upper abdominal surgery, or long operation time is a risk factor of PPC in patients with COPD. Adequate inhaled corticosteroids treatment in patients with eosinophilic asthma and introducing treatment for COPD in patients with COPD could reduce PPCs.

Download PDF

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: Job vacancy: Paediatric Clinical Research Nurse, Guy's and St Thomas' NHS Foundation Trust, London… https://t.co/kdWOhiMk8D
4hreplyretweetfavorite
Interasma RT @SocLatAlergia: Abierto el plazo para el envío de trabajos libres. https://t.co/3F3ZTY50oR https://t.co/aQSnTdOTSn
7hreplyretweetfavorite
Interasma RT @worldallergy: WISC 2019: You Are Invited to Attend! Registration and Abstract Submission are Now Open https://t.co/YKCvRwdO1j
7hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: Job vacancy: Paediatric Clinical Research Nurse, Guy's and St Thomas' NHS Foundation Trust, London https://t.co/hm
9hreplyretweetfavorite
Interasma RT @Aller_MD: “Researchers identify comprehensive guidelines for managing severe atopic dermatitis” https://t.co/jh5FxCO1QW https://t.co/FS
9hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma